Editor's Observe: This story initially appeared on KFF Well being Information. SAN DIEGO — Erinn Maury knew Remicade wasn’t the fitting drug for Patti Schulte, a rheumatoid arthritis affected person the doctor noticed at her Millersville, Maryland, apply. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two medication in the identical class. However the insurer insisted, so Schulte went on Remicade.
